STOCK TITAN

United-Guardian, Inc. - UG STOCK NEWS

Welcome to our dedicated news page for United-Guardian (Ticker: UG), a resource for investors and traders seeking the latest updates and insights on United-Guardian.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect United-Guardian's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of United-Guardian's position in the market.

Rhea-AI Summary
United-Guardian, Inc. reports a relatively flat net income for FY 2023 compared to FY 2022, with a 14% decrease in net sales. The decrease in sales was primarily due to lower sales of cosmetic ingredients and a supply disruption for their main pharmaceutical product, Renacidin, in 2023. Despite challenges, the company remains optimistic for 2024 with new orders of Renacidin and ongoing distributor negotiations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.07%
Tags
-
Rhea-AI Summary
United-Guardian, Inc. (UG) has declared a cash dividend of $0.25 per share, to be paid on February 20, 2024, to all stockholders of record as of February 12, 2024. This represents a significant increase over the previous year's dividend of $0.10 per share. The company aims to balance its capital requirements with the interests of its stockholders, ensuring sufficient capital to support growth targets and expanded marketing activities in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.01%
Tags
dividends
-
News
Rhea-AI Summary
United-Guardian, Inc. (UG) appoints Catherine Joy Kolinski as the newest director, bringing over 30 years of experience in personal care, pharmaceutical, and industrial sectors. With a background in chemistry and executive business management, she will provide valuable insight and guidance for the company's growth plan.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management
Rhea-AI Summary
United-Guardian, Inc. (NASDAQ:UG) announced financial results for Q3 and first nine months of 2023. Q3 sales increased to $3,057,518 from $2,417,022, with net income rising to $626,756 from $345,518. Sales for the nine-month period decreased to $8,278,141 from $9,935,557, while net income decreased to $1,843,931 from $1,890,307. Sales increased in all main product categories, with cosmetic ingredient sales up 42%, pharmaceutical sales up 3%, and medical lubricant sales up 73%. The company plans to implement changes in its marketing strategy in Q1 2024 to increase sales.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
27.81%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.78%
Tags
-
Rhea-AI Summary
United-Guardian, Inc. (NASDAQ:UG) declared a cash dividend of $0.10 per share, to be paid on August 2, 2023, to all stockholders of record. This will be the 28th consecutive year of dividend payments. The company's Board of Directors decided to retain more earnings for future growth development. United-Guardian is a manufacturer of cosmetic ingredients, personal and health care products, and pharmaceuticals.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.5%
Tags
dividends
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.84%
Tags
management
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.73%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.88%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.93%
Tags
United-Guardian, Inc.

Nasdaq:UG

UG Rankings

UG Stock Data

35.15M
2.92M
36.39%
23.29%
0.04%
All Other Miscellaneous Chemical Product and Preparation Manufacturing
Manufacturing
Link
United States
Hauppauge

About UG

the company performs research and development in the areas of cosmetic ingredients, medical products, pharmaceuticals, and industrial products. we have been in business since 1942, and sell our products through a global network of marketing partners to most ot the global cosmetic companies. the most important product line is an extensive line of water-based moisturizing and lubricating gels, which have both cosmetic and medical applications.